1-15 of 15
John Clifford
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 6332: Targeting PARP for the prevention of BRCA1-deficient triple-negative breast cancers

Free
Amanda Lanier, John Clifford, Jamal Hill, Darian Coleman, Cassandra Moyer, Alejandro Contreras, Mark Albertella, Anna Staniszewska, Andrew Reynolds, Shizuko Sei, Powel Brown, Abhijit Mazumdar
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_1): 6332.
https://doi.org/10.1158/1538-7445.AM2025-6332
Published: 21 April 2025
View article titled, Abstract 6332: Targeting PARP for the prevention of BRCA1-deficient triple-negative breast cancers
Journal Articles

Abstract 7302: Effect of estrogen receptor modulator bazedoxifene on progression of carcinogen induced bladder cancer in female F344 rats

Free
Venkateshwar Madka, Gopal Pathuri, Surya P. Singh, Srikanth Chiliveru, Anil Singh, Anh Bao, Nicole Stratton, Clinton J. Grubbs, Shizuko Sei, John Clifford, Brian Cholewa, Chinthalapally V. Rao
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 7302.
https://doi.org/10.1158/1538-7445.AM2024-7302
Published: 22 March 2024
View article titled, Abstract 7302: Effect of estrogen receptor modulator bazedoxifene on progression of carcinogen induced bladder cancer in female F344 rats
Journal Articles

Abstract 3675: The role of the mitotic spindle protein RHAMM in early stage bladder malignancy.

Free
Randolph Stone, Anita Sabichi, Jennifer Gill, Patrick Adegboyega, Heather Kleiner, Nathan Davis, Shari Meyers, John Clifford
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 3675.
https://doi.org/10.1158/1538-7445.AM2013-3675
Published: 15 April 2013
View article titled, Abstract 3675: The role of the mitotic spindle protein RHAMM in early stage bladder malignancy.
Journal Articles

Abstract 1363: Development of novel anticancer agents based on fusarochromanone

Free
Elahe Mahdavian, Dakota Boston, Reid Grimes, Tara Williams-Hart, Brian Furmanski, John Clifford, Brian Salvatore
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 1363.
https://doi.org/10.1158/1538-7445.AM2011-1363
Published: 15 April 2011
View article titled, Abstract 1363: Development of novel anticancer agents based on fusarochromanone
Journal Articles

Abstract 4861: Identification of premalignant bladder markers using DNA microarray analysis of the UPII-SV40Tag model for invasive bladder UCC

Free
Randolph Stone, Anita Sabichi, Jennifer Gill, I-Ling Lee, Urska Cvek, Marjan Trutschl, Patrick Adegboyega, Michael Dai, Rasiah Loganantharaj, John Clifford
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 4861.
https://doi.org/10.1158/1538-7445.AM2011-4861
Published: 15 April 2011
View article titled, Abstract 4861: Identification of premalignant bladder markers using DNA microarray analysis of the UPII-SV40Tag model for invasive bladder UCC
Journal Articles

Abstract #4695: Novel 2-thiazol or 2-thiophen-substituted quinazolinone derivatives with significant anti-tumor effects

Free
Jennifer Carroll, Lisa Adams, Donna Rogers, John Clifford, Heather Kleiner, Tammy Dugas, Kenneth McMartin, Brian Latimer, Rajan Giri, Kamala Vasu, Anthony Giordano, Briana Williams
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 4695.
Published: 01 May 2009
View article titled, Abstract #4695: Novel 2-thiazol or 2-thiophen-substituted quinazolinone derivatives with significant anti-tumor effects
Journal Articles

Dominant negative STAT3 suppresses survival, HGF-induced motility, and invasion in malignant squamous cell carcinoma cells.

Free
Zanobia Syed, Satish Cheepala, Weihong Yin, Jennifer Gill, John Clifford
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 3408.
Published: 01 May 2008
View article titled, Dominant negative STAT3 suppresses survival, HGF-induced motility, and invasion in malignant squamous cell carcinoma cells.
Journal Articles

All-trans retinoic acid suppresses skin carcinogenesis by suppressing the B-Raf/Mek/Erk pathway.

Free
Satish Cheepala, Syed Zanobia, Insun Chong, Jennifer Gill, Mark Lynch, Marjan Trutschl, Urska Cvek, John Clifford
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 483.
Published: 01 May 2008
View article titled, All-trans retinoic acid suppresses skin carcinogenesis by suppressing the B-Raf/Mek/Erk pathway.
Journal Articles

Novel derivatives of fusarochromanone: potential therapeutic compounds

Free
Elahe Mahdavian, Brian Salvatore, John Clifford
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 3975.
Published: 01 May 2007
View article titled, Novel derivatives of fusarochromanone: potential therapeutic compounds
Journal Articles

The Raf/Mek/Erk MAP kinase pathway is a target for all-trans retinoic acid (ATRA) suppression of skin carcinogenesis.

Free
Satish Cheepala, Zanobia Syed, Weihong Yin, Jennifer Roberts, Marjan Trutschl, Urska Cvek, Susan Fischer, John Clifford
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 2893.
Published: 01 May 2007
View article titled, The Raf/Mek/Erk MAP kinase pathway is a target for all-trans retinoic acid (ATRA) suppression of skin carcinogenesis.
Journal Articles

Phase III trial of adjuvant 13-cis-retinoic acid and interferon-alpha for patients with aggressive skin squamous cell carcinoma.

Free
Abenaa M. Brewster, J. Jack Lee, Gary Clayman, John Clifford, Mary Jo Necesito Reyes, Xian Zhou, Anita Sabichi, Sara Strom, Robert Collins, Christina Meyers, Scott Lippman
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 1330.
Published: 15 April 2006
View article titled, Phase III trial of adjuvant 13-cis-retinoic acid and interferon-alpha for patients with aggressive skin squamous cell carcinoma.
Journal Articles

Stage-specific disruption of Stat3 demonstrates a requirement during both initiation and promotion stages of mouse skin tumorigenesis

Free
Ken Kataoka, Dae Joon Kim, Keith Syson Chan, Shigetoshi Sano, Steve Carbajal, Lori Hollek, John Clifford, John Digiovanni
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 667.
Published: 15 April 2006
View article titled, Stage-specific disruption of Stat3 demonstrates a requirement during both initiation and promotion stages of mouse skin tumorigenesis
Journal Articles

Temporally controlled disruption in Stat3 demonstrates a requirement for mouse skin tumor promotion

Free
Ken Kataoka, Keith Syson Chan, Shigetoshi Sano, Steve Carbajal, Lori Hollek, John Clifford, John Digiovanni
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 615.
Published: 01 May 2005
View article titled, Temporally controlled disruption in Stat3 demonstrates a requirement for mouse skin tumor promotion
Journal Articles

Forced expression of a constitutively active form of Stat3 in epidermis reveals a novel role in malignant conversion of skin tumors

Free
Keith S. Chan, Shigetoshi Sano, Ken Kataoka, Steve Carbajal, John Clifford, Mary Peavey, John Digiovanni
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1345.
Published: 01 May 2005
View article titled, Forced expression of a constitutively active form of Stat3 in epidermis reveals a novel role in malignant conversion of skin tumors
Journal Articles

Epidermal Growth Factor Receptor-Mediated Activation of Stat3 during Multistage Skin Carcinogenesis

Free
Keith Syson Chan, Steve Carbajal, Kaoru Kiguchi, John Clifford, Shigetoshi Sano, John DiGiovanni
Journal: Cancer Research
Cancer Res (2004) 64 (7): 2382–2389.
https://doi.org/10.1158/0008-5472.CAN-03-3197
Published: 01 April 2004
View article titled, Epidermal Growth Factor Receptor-Mediated Activation of Stat3 during Multistage Skin Carcinogenesis
Open the PDF for Epidermal Growth Factor Receptor-Mediated Activation of Stat3 during Multistage Skin Carcinogenesis in another window